PAR 5.88% 24.0¢ paradigm biopharmaceuticals limited..

Ann: Phase 3 OA Trial to Proceed after Formal Safety Review, page-12

  1. 106 Posts.
    lightbulb Created with Sketch. 26
    Thank you all for the feedback.
    I personally only started buying shares in 2018 and have invested quite heavily in PAR.
    HC has become a daily read for me, sometimes informative, sometimes comical and sometimes ignorable.
    I had advice prior to entering the stock market…
    don’t risk what you can’t afford to lose, if you decide to buy spec, you have to believe the story and research, research, research.
    only one problem the more I researched the more I started to ignore the first bit of advice.
    looking forward to 2023, I think it is going to be exciting for PAR and all it’s holders
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.015(5.88%)
Mkt cap ! $84.05M
Open High Low Value Volume
25.5¢ 26.5¢ 24.0¢ $167.2K 671.5K

Buyers (Bids)

No. Vol. Price($)
3 108741 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 9700 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.